U.S. Food and Drug Administration (OPDP / CBER Advertising and Promotional Labeling Branch) · United States

FDCA 502(n) - Adverse Event Reporting Statement in Published DTC Ads

Published consumer-directed prescription drug ads must include, in conspicuous text, the statutory statement encouraging consumers to report negative side effects to FDA via MedWatch.

21 U.S.C. 352(n) (FD&C Act 502(n), FDAAA 2007 s.906)

What is FDCA 502(n) - Adverse Event Reporting Statement in Published DTC Ads?

Published consumer-directed prescription drug ads must include, in conspicuous text, the statutory statement encouraging consumers to report negative side effects to FDA via MedWatch. Apply to consumer-directed print and published digital ads that name a prescription drug and make a product claim.

US Federal

Read official source

Last reviewed: 2026-11-05

General information, not legal advice.

Who does this rule apply to?

general_audience, general_adults_18plus, customers, patients · Prescription Drug · pharma

Where does this rule apply?

United States

Which marketing channels are covered?

print, digital, display, social_media

When does this rule take effect?

2026-10-07

What does this rule require?

Published consumer-directed prescription drug ads must include, in conspicuous text, the statutory statement encouraging consumers to report negative side effects to FDA via MedWatch.

How can marketing teams comply?

Apply to consumer-directed print and published digital ads that name a prescription drug and make a product claim.

Where can I read the official source?

Read official source

Key facts

Regulatory authority
U.S. Food and Drug Administration (OPDP / CBER Advertising and Promotional Labeling Branch)
Jurisdiction
United States
Official citation
21 U.S.C. 352(n) (FD&C Act 502(n), FDAAA 2007 s.906)
Published
2026-11-16
Effective date
2026-10-07
Channel
print, digital, display, social_media
Products
Prescription Drug
Audiences
general_audience, general_adults_18plus, customers, patients

Frequently asked questions

What is FDCA 502(n) - Adverse Event Reporting Statement in Published DTC Ads?

Published consumer-directed prescription drug ads must include, in conspicuous text, the statutory statement encouraging consumers to report negative side effects to FDA via MedWatch.

Who does this rule apply to?

general_audience, general_adults_18plus, customers, patients · Prescription Drug · pharma

Where does this rule apply?

United States

Which marketing channels are covered?

print, digital, display, social_media

When does this rule take effect?

2026-10-07

Request a free compliance scan of your homepage and book a time with Warrant.

Get a free homepage compliance scan